Replies to post #32027 on Biotech Values

[DewDiligence]

> ENCY – The reason I believe that it should be approved here is because according to all of the data out there including the fact that Encysive even did a study where they did a head to head of their drug vs Tracleer, Encysive's drug Thelin, was clearly safer and had better efficacy than Tracleer.<

ENCY did not run a bona fide head-to-head study of Thelin vs Tracleer; rather, they included an open-label Tracleer arm in the phase-3 trial.